The combined activity of the EBV-associated latent membrane protein 1 (LMP1) and IFN could further boost PD-L1 expression in Epstein–Barr virus (EBV)-positive nasopharyngeal carcinoma cells [99]. Here, CD274 is linked to nasopharyngeal carcinoma.